BVXV - BiondVax Pharmaceuticals Ltd. (BVXV) CEO Amir Reichman on Q4 2021 Results - Earnings Call Transcript
BiondVax Pharmaceuticals Ltd. (BVXV) Q4 2021 Earnings Conference Call April 04, 2022 10:00 AM ET Company Participants Kenny Green - Edison Group, IR Josh Phillipson - Director of Business Development and Investor Relations Amir Reichman - Chief Executive Officer Matthias Dobbelstein - Professor at University Medical Center, Gottingen Presentation Kenny Green Hi everyone. Good day. I would like to welcome all of you to BiondVax's Webinar. My name is Kenny Green from Edison Group and I'm part of the IR team at BiondVax. I would like to remind everyone that this conference call today is being recorded and the recording will be available later today on BiondVax's Investor Relations Web site. Please note that this conference call will contain projections or other forward-looking statements regarding future events or the future performance of the company. These statements are only predictions and BiondVax cannot guarantee that they will in fact occur. BiondVax
For further details see:
BiondVax Pharmaceuticals Ltd. (BVXV) CEO Amir Reichman on Q4 2021 Results - Earnings Call Transcript